EU to Livestream Public Hearing on Monsanto Papers
By Jennifer Sass
Without much fanfare on this side of the Atlantic, the European Union is actively and effectively pushing back on one of the biggest bullies in the corporate sandbox, Monsanto.
This week in Brussels the European Parliament's Environment and Agriculture committees will hold a public hearing on The Monsanto Papers, documents released through lawsuits in the U.S. brought against Monsanto by over 250 people alleging that exposure to Roundup herbicide is responsible for their cancers.
The papers show a disturbing pattern of scientific misrepresentation, data manipulation and collusion with government officials. The hearing is called, 'The Monsanto Papers and Glyphosate' (11 Oct 9-12:30, AGRI/ENVI joint hearing) and will be live web-streamed starting at 3 a.m. EST (agenda here).
Monsanto was invited to testify at the hearing and to explain itself, but chose to skip the event, on the grounds that it would be political and Monsanto argues that the issue is purely scientific. In response, the EU Parliament banned Monsanto lobbyists from entering the parliament. AgroNews noted that this will be a setback for the multinational corporation, which spent €300,000-€400,000 lobbying in Brussels in 2015-2016 (about $450,000 USD), presumably to exercise its influence over the political process.
EU Parliament Bans Monsanto Lobbyists https://t.co/WiSWnfbmxV @OrganicConsumer @eartheats— EcoWatch (@EcoWatch)1506632453.0
The European Commission (EC) is the executive branch that proposes and implements legislation and represents European interests. It implements the decisions of the European Parliament, which represents the citizens, and the Council of Ministers, which represents the national interests of the 28 member states. The Parliament is holding the hearing, but the Commission will hold the vote in November or December on whether to approve continued use of glyphosate.
How did Monsanto get itself into this pickle?
The World Health Organizations' (WHO) cancer assessment arm, the International Agency for Research on Cancer (IARC) reviewed toxicity studies in lab rodents linking glyphosate to cancers. There were also publicly available epidemiologic studies linking the formulated product, Roundup, to cancers and DNA-damage in exposed workers. IARC did a full scientific review, concluding in March 2015 that glyphosate, the main ingredient in Roundup, was "probably" carcinogenic to people (Group 2A), based upon three lines of evidence: "sufficient" evidence of cancer in mice and rats that were fed glyphosate over a several years; "strong" evidence from mechanistic or cellular studies that explain how glyphosate may cause cancer; "limited" evidence from epidemiologic studies of people, particularly pesticide applicators and farmworkers.
Monsanto product defense strategy
Monsanto strongly denies the IARC conclusions, and continues to argue that its highly profitable weed killer is "safe." Nonetheless, IARC's cancer assessment sparked a Monsanto-fueled firestorm of product defense activities in both the EU and the U.S.:
Monsanto at EFSA - Stepping into line with much the same talking points as Monsanto, the European Food Safety Authority (EFSA) gave its blessing to glyphosate (November 2015). But now we know that its report largely came from Monsanto; using a combination of manual and automatic text comparison software, the risk assessment authored by the German Federal Institute for Risk Assessment (BfR) that formed EFSA's final report proved to be plagiarized from Monsanto. Based on the 2015 EFSA approval, the European Commission was set to renew its approval of glyphosate for another 15 years, as has been the normal routine in the past. However, following public outcry over cancer risks, the approval failed to garner support from enough countries so in June 2016 the Commission instead gave approval only for a limited extension until the end of this year, December 15, 2017. The Commission is expected to hold a vote later this year (November or December 2017).
Monsanto at JMPR - The European Joint Food and Agriculture Organization (FAO)/WHO Meeting on Pesticide Residues (JMPR) also declared glyphosate unlikely to pose a cancer risk to people from exposures through the diet (food and water) (JMPR May 2016). NRDC identified JMPR members with financial ties to the pesticide industry, making the committee biased and conflicted.
Monsanto at U.S. EPA - The U.S. Environmental Protection Agency (EPA) also fell in behind Monsanto, with its October 2015 Cancer Assessment Review Committee (CARC) proposing to classify glyphosate as "not likely to be carcinogenic to humans" (CARC 2015). The head of the committee that issued the report, Jess Rowland, was subsequently shown to have a too cozy relationship with Monsanto. In an internal Monsanto email released as part of the litigation 'Monsanto Papers' Rowland bragged to Monsanto in an April 2015 telephone conversation that he deserved a medal if he could kill an investigation by another federal agency (ATSDR) into the cancer risks of glyphosate. That investigation was subsequently abandoned (see Bloomberg News 2017; USRTK.org). Monsanto's regulatory liaison wrote in a 2015 email that Rowland, "could be useful to us as we move forward with ongoing glyphosate defense." Rowland has since left EPA. The EPA Inspector General launched an investigation into possible collusion between EPA employees and Monsanto (May, 2017).
U.S. EPA continues to defend glyphosate, issuing a report in September 2016 that also proposed that glyphosate was "not likely" to cause cancer in humans. Scrutiny by the EPA Scientific Advisory Panel in December 2016 gave EPA's proposed classification a mixed review, with some recommending that it should be more protective (suggestive evidence of cancer) and all members agreeing that EPA failed to follow its own Cancer Guidelines (SAP final report, March 2017)—NRDC also made these recommendations in scientific comments to the SAP. Unfortunately, the Pruitt-Trump EPA has thus far left the proposed "not likely" classification in place, with a final determination expected by the end of this year.
Monsanto and U.S. Congress - Earlier this year, January 2017, U.S. Congressional Republicans launched an investigation into IARC's review of glyphosate, which appears to be laying the groundwork for Republican-led efforts to cut U.S. funding for IARC. The drumbeat has been picked up by chemical manufacturer lobbyists (ACC), and even press outlets including Reuters reporting on Monsanto talking points.
Monsanto in California - Monsanto launched an unsuccessful legal challenge to block the California Office of Environmental Health Hazard Assessment's proposal to add glyphosate to the Proposition 65 list, following the IARC determination that glyphosate poses a cancer risk. Monsanto disagreed with California voters' choice to make IARC findings an independent ground for adding carcinogens to the Proposition 65 list and challenged it as unconstitutional. The court rejected Monsanto's arguments. NRDC and others successfully intervened in the case, alongside California (March 2017).
Whether Monsanto will prevail in its legal and propaganda war against IARC and its defense of glyphosate remains to be seen. The European Commission will vote on whether to extend its approval of glyphosate—and if so, for how long—by the end of this year. At the same time, Monsanto-fueled efforts to defund the IARC program remain a threat during budget negotiations here in the U.S., which may also extend to the end of this year. Meanwhile, EPA's draft human health risk assessment for glyphosate is also expected by the end of this year.
But the steady drip, drip, drip of the documents coming from the lawsuit against Monsanto continues to put the company, and its defenders, including EPA and EFSA, in an increasingly awkward and untenable position. Let's hope that European legislators and the public get sufficiently fed up with Monsanto's methods and take serious steps to restrict or eliminate Roundup's use. This would have a potentially profound effect upon glyphosate-related policies here in the U.S., where EPA appears to still be taking its cues from Monsanto.
The European Parliament's hearing across the pond may be the next step in the dismantling of Monsanto's almost universal wall of support from regulatory agencies around the globe. Eventually, the truth will win out. Stay tuned!Jennifer Sass is a senior scientist in the Health and Environment program of the the Natural Resources Defense Council.
- New Clues Help Monarch Butterfly Conservation Efforts - EcoWatch ›
- Monarch Butterflies Will Be Protected Under Historic Deal - EcoWatch ›
EcoWatch Daily Newsletter
California faces another "critically dry year" according to state officials, and a destructive wildfire season looms on its horizon. But in a state that welcomes innovation, water efficacy approaches and drought management could replenish California, increasingly threatened by the climate's new extremes.
- Remarkable Drop in Colorado River Water Use Sign of Climate ... ›
- California Faces a Future of Extreme Weather - EcoWatch ›
Wisdom the mōlī, or Laysan albatross, is the oldest wild bird known to science at the age of at least 70. She is also, as of February 1, a new mother.
<div id="dadb2" class="rm-shortcode" data-rm-shortcode-id="aa2ad8cb566c9b4b6d2df2693669f6f9"><blockquote class="twitter-tweet twitter-custom-tweet" data-twitter-tweet-id="1357796504740761602" data-partner="rebelmouse"><div style="margin:1em 0">🚨Cute baby alert! Wisdom's chick has hatched!!! 🐣😍 Wisdom, a mōlī (Laysan albatross) and world’s oldest known, ban… https://t.co/Nco050ztBA</div> — USFWS Pacific Region (@USFWS Pacific Region)<a href="https://twitter.com/USFWSPacific/statuses/1357796504740761602">1612558888.0</a></blockquote></div>
By Hui Hu
Winter is supposed to be the best season for wind power – the winds are stronger, and since air density increases as the temperature drops, more force is pushing on the blades. But winter also comes with a problem: freezing weather.
Comparing rime ice and glaze ice shows how each changes the texture of the blade. Gao, Liu and Hu, 2021, CC BY-ND
Ice buildup changes air flow around the turbine blade, which can slow it down. The top photos show ice forming after 10 minutes at different temperatures in the Wind Research Tunnel. The lower measurements show airflow separation as ice accumulates. Icing Research Tunnel of Iowa State University, CC BY-ND
While traditional investment in the ocean technology sector has been tentative, growth in Israeli maritime innovations has been exponential in the last few years, and environmental concern has come to the forefront.
theDOCK aims to innovate the Israeli maritime sector. Pexels<p>The UN hopes that new investments in ocean science and technology will help turn the tide for the oceans. As such, this year kicked off the <a href="https://www.oceandecade.org/" target="_blank" rel="noopener noreferrer">United Nations Decade of Ocean Science for Sustainable Development (2021-2030)</a> to galvanize massive support for the blue economy.</p><p>According to the World Bank, the blue economy is the "sustainable use of ocean resources for economic growth, improved livelihoods, and jobs while preserving the health of ocean ecosystem," <a href="https://www.sciencedirect.com/science/article/pii/S0160412019338255#b0245" target="_blank" rel="noopener noreferrer">Science Direct</a> reported. It represents this new sector for investments and innovations that work in tandem with the oceans rather than in exploitation of them.</p><p>As recently as Aug. 2020, <a href="https://www.reutersevents.com/sustainability/esg-investors-slow-make-waves-25tn-ocean-economy" target="_blank" rel="noopener noreferrer">Reuters</a> noted that ESG Investors, those looking to invest in opportunities that have a positive impact in environmental, social and governance (ESG) issues, have been interested in "blue finance" but slow to invest.</p><p>"It is a hugely under-invested economic opportunity that is crucial to the way we have to address living on one planet," Simon Dent, director of blue investments at Mirova Natural Capital, told Reuters.</p><p>Even with slow investment, the blue economy is still expected to expand at twice the rate of the mainstream economy by 2030, Reuters reported. It already contributes $2.5tn a year in economic output, the report noted.</p><p>Current, upward <a href="https://www.ecowatch.com/-innovation-blue-economy-2646147405.html" target="_self">shifts in blue economy investments are being driven by innovation</a>, a trend the UN hopes will continue globally for the benefit of all oceans and people.</p><p>In Israel, this push has successfully translated into investment in and innovation of global ports, shipping, logistics and offshore sectors. The "Startup Nation," as Israel is often called, has seen its maritime tech ecosystem grow "significantly" in recent years and expects that growth to "accelerate dramatically," <a href="https://itrade.gov.il/belgium-english/how-israel-is-becoming-a-port-of-call-for-maritime-innovation/" target="_blank" rel="noopener noreferrer">iTrade</a> reported.</p><p>Driving this wave of momentum has been rising Israeli venture capital hub <a href="https://www.thedockinnovation.com/" target="_blank" rel="noopener noreferrer">theDOCK</a>. Founded by Israeli Navy veterans in 2017, theDOCK works with early-stage companies in the maritime space to bring their solutions to market. The hub's pioneering efforts ignited Israel's maritime technology sector, and now, with their new fund, theDOCK is motivating these high-tech solutions to also address ESG criteria.</p><p>"While ESG has always been on theDOCK's agenda, this theme has become even more of a priority," Nir Gartzman, theDOCK's managing partner, told EcoWatch. "80 percent of the startups in our portfolio (for theDOCK's Navigator II fund) will have a primary or secondary contribution to environmental, social and governance (ESG) criteria."</p><p>In a company presentation, theDOCK called contribution to the ESG agenda a "hot discussion topic" for traditional players in the space and their boards, many of whom are looking to adopt new technologies with a positive impact on the planet. The focus is on reducing carbon emissions and protecting the environment, the presentation outlines. As such, theDOCK also explicitly screens candidate investments by ESG criteria as well.</p><p>Within the maritime space, environmental innovations could include measures like increased fuel and energy efficiency, better monitoring of potential pollution sources, improved waste and air emissions management and processing of marine debris/trash into reusable materials, theDOCK's presentation noted.</p>
theDOCK team includes (left to right) Michal Hendel-Sufa, Head of Alliances, Noa Schuman, CMO, Nir Gartzman, Co-Founder & Managing Partner, and Hannan Carmeli, Co-Founder & Managing Partner. Dudu Koren<p>theDOCK's own portfolio includes companies like Orca AI, which uses an intelligent collision avoidance system to reduce the probability of oil or fuel spills, AiDock, which eliminates the use of paper by automating the customs clearance process, and DockTech, which uses depth "crowdsourcing" data to map riverbeds in real-time and optimize cargo loading, thereby reducing trips and fuel usage while also avoiding groundings.</p><p>"Oceans are a big opportunity primarily because they are just that – big!" theDOCK's Chief Marketing Officer Noa Schuman summarized. "As such, the magnitude of their criticality to the global ecosystem, the magnitude of pollution risk and the steps needed to overcome those challenges – are all huge."</p><p>There is hope that this wave of interest and investment in environmentally-positive maritime technologies will accelerate the blue economy and ESG investing even further, in Israel and beyond.</p>
- 14 Countries Commit to Ocean Sustainability Initiative - EcoWatch ›
- These 11 Innovations Are Protecting Ocean Life - EcoWatch ›
- How Innovation Is Driving the Blue Economy - EcoWatch ›